Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-sen University
George Washington University
Groupe Oncologie Radiotherapie Tete et Cou
University of Michigan Rogel Cancer Center
University of Arizona
University of Leipzig